Bionaut Labs raises $43M for drug delivery robots

-

Bionaut Labs, a robotic drug delivery technology developer, closed a Series B financing round worth $43.2 million. Los Angeles-based Bionaut Labs uses microscale robots to deliver drugs for treating central nervous system (CNS) diseases and disorders. Through magnetic propulsion, the company’s Bionauts can navigate the human body and deliver drugs locally.

The technology can reach deep locations in the midbrain with precision, going beyond the blood-brain barrier. This generates efficiency and helps to avoid side effects and toxicity from systemically delivered drugs. Bionaut aims to develop solutions for conditions including Parkinson’s disease, Huntington’s disease, malignant glioma and hydrocephalus.

Funds raised in the Series B round are earmarked for advancing the clinical development of Bionaut’s lead programs. Those programs include treatments for malignant glioma brain tumors and Dandy-Walker Syndrome (a rare pediatric neurological disorder). The company also plans to use funds to support further development of the proprietary Bionaut treatment platform.

Bionaut Labs microrobots

Bionaut plans to release major pre-clinical data packages from IDE- and IND-enabling studies in 2023. It aims to initiate human clinical trials in 2024.

Khosla Ventures led the financing, bringing Bionaut’s funds raised to date to $63.2 million. New investors Deep Insight, OurCrowd, PSPRS, Sixty Degree Capital, Dolby Family Ventures, GISEV Family Ventures, What if Ventures, Tintah Grace and Gaingels participated. Existing investors Upfront Ventures, BOLD Capital Partners, Revolution VC, and Compound also participated.

“There has been a dearth of innovation around treatments for conditions that cause tremendous suffering, in large part because past failures have discouraged even the best of researchers,” said Michael Shpigelmacher, co-founder and CEO, Bionaut Labs. “Bionaut Labs remains committed to finding new ways to treat these devastating diseases, which are long overdue for a breakthrough.”

The post Bionaut Labs raises $43M for drug delivery robots appeared first on The Robot Report.



from The Robot Report - Robotics News, Analysis & Research https://ift.tt/RlBda15
via artificialconference

Comments

Post a Comment

Popular posts from this blog

Valiant TMS and Realtime Robotics partner to cut programming, cycle times

-
Image
Valiant TMS is integrating robot motion optimization as a service. Source: Realtime Robotics Realtime Robotics today announced that Valiant TMS will integrate its Optimization-as-a-Service offering with customers’ manufacturing operations. The companies said the combination of Realtime’s proprietary software and engineering expertise with Valiant TMS’s manufacturing industry experience will improve the efficiency and productivity of automated operations. With Optimization-as-a-Service, companies can identify and eliminate production bottlenecks, significantly reducing cycle time and programming time, said Realtime Robotics. “Manufacturers are always looking for ways to improve their production processes, but few have the time or resources to spend on such a lengthy, involved task,” said Peter Howard, CEO of Realtime Robotics, in a release . “We’re thrilled that our optimization solution has struck a chord with so many, automating the task of generating and testing potential layou...
Read more

Ocado wins UK patent lawsuit over Autostore

-
Image
On the left, Autostore’s ASRS, and on the right, Ocado’s ASRS. | Source: Autostore, Ocado Yesterday, the UK High Court ruled that Autostore’s patents, which have been the subject of a patent infringement case against Ocado , were invalid, and that Ocado did not infringe upon them. Both Autostore and Ocado operate automated storage and retrieval systems (ASRS) that operate on similar principles. Autostore filed the lawsuit in October 2020, when it asserted that Ocado infringed upon six of its patents. The European Patent Office invalidated two of these patents before judgment was made on the case, and two other patents were withdrawn by Autostore before the hearing started.  Judge Hacon invalidated the remaining two patents because AutoStore had disclosed its technology publically in a business deal with the Central Bank of Russia before the company filed its patents. Halcon ruled that even if the patents were valid, the Ocado Smart Platform (OSP) did not infringe on the...
Read more

Update on AgTech automation at CNHI

-
Image
The Robot Report Podcast · Update on AgTech automation at CNHI The Robot Report Podcast · 2023 year in review: GenAI, humanoids dominate robotics industry   In Episode 138 of The Robot Report Podcast, co-hosts Mike Oitzman and Eugene Demaitre catch up with Marc Kermisch, global chief digital and information officer at CNH Industrial, or CNHI. Kermisch takes us through the latest developments at CNHI in agriculture autonomy and digitization, explaining how robots and data can help farmers and growers improve yields and efficiency. We also recap the latest robotics news and walk through an update from robotics and automation companies that attended this month’s 2024 CES show. News of the week Locus Robotics layoffs The mobile robot maker last week confirmed that it had a “small, targeted RIF,” or reduction in force. North American robot orders dropped last year, according to the Association for Advancing Automation ( A3 ). Warehouse construction also declined by 2...
Read more